v3.22.2.2
Other Financial Information - Inventories (Details) - USD ($)
$ in Millions
Oct. 02, 2022
Dec. 31, 2021
Other Financial Information [Abstract]    
Finished goods $ 3,159 $ 3,641
Work-in-process 4,540 4,424
Raw materials and supplies 1,813 994
Inventories [1] 9,513 9,059
Noncurrent inventories not included above [2] $ 3,327 $ 939
[1] The increase from December 31, 2021 primarily reflects higher inventory levels for Paxlovid, partially offset by decreases due to net supply recovery and inventory build, and market demand.
[2] Included in Other noncurrent assets. The increase from December 31, 2021 is primarily due to strategic inventory build related to Paxlovid. There are no recoverability issues for these amounts.